Earnings Call · Q2 FY2021·2021-08-09

Q2 21EPS -100.00%*·Rev n/aQ1 21EPS +14.40%·Rev n/aQ4 20EPS -100.00%*·Rev n/aQ3 20EPS +100.00%*·Rev n/a⚠ consensus missing

KYNTRA BIO, INC. FGEN

Michael Tung — Vice President of Corporate Strategy and Investor Relations

Enrique Conterno — Chief Executive Officer

Pat Cotroneo — Chief Financial Officer

−4.4%1d on move date−4.5% vs SPY3d−8.7%5d−12.8%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more FGEN calls or request research access.

More FGEN calls Browse calls Request research access